Tumor-specific anti-nucleosome antibody improves therapeutic efficacy of doxorubicin-loaded long-circulating liposomes against primary and metastatic tumor in mice.
about
Micelle-like nanoparticles as carriers for DNA and siRNAQuantum dot loaded immunomicelles for tumor imaging.Targeted Nanodelivery of Drugs and DiagnosticsLuteinizing hormone-releasing hormone receptor-mediated delivery of mitoxantrone using LHRH analogs modified with PEGylated liposomesRelease of liposomal contents by cell-secreted matrix metalloproteinase-9Doxorubicin liposomes as an investigative model to study the skin permeation of nanocarriers.Multifunctional, stimuli-sensitive nanoparticulate systems for drug deliveryExtracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery.Doxorubicin in TAT peptide-modified multifunctional immunoliposomes demonstrates increased activity against both drug-sensitive and drug-resistant ovarian cancer models.Liposomal cancer therapy: exploiting tumor characteristics.Stimulus-responsive macromolecules and nanoparticles for cancer drug delivery.Nanomaterials: applications in cancer imaging and therapy.Challenges in development of targeted liposomal therapeutics.Liposomes and their applications in molecular imaging.Immunoconjugates and long circulating systems: origins, current state of the art and future directionsNanomedicine as an emerging platform for metastatic lung cancer therapy.Quantum dot-mediated delivery of siRNA to inhibit sphingomyelinase activities in brain-derived cells.Cetuximab Immunoliposomes Enhance Delivery of 5-FU to Skin Squamous Carcinoma Cells.Antibody-targeted nanoparticles for cancer treatment.Nanosized multifunctional liposomes for tumor diagnosis and molecular imaging by SPECT/CT.
P2860
Q27001558-507E2680-FDC6-427C-B689-5D7FEDAA534CQ33721349-1E1AE22A-D640-4143-8427-B597A67B2BA3Q33900258-43AE6E80-E9A5-41FE-96F9-F3B7AB295F11Q34170191-625B33B5-7332-443C-9FFD-D294DB507FD7Q35636788-561FE8DB-59D2-4289-AD68-AFC03E8AD544Q35772168-2E7DFDC8-6041-40BA-A34A-8677A0CCBB20Q35809872-9041718F-7694-4FFC-8BEE-E187D34D9324Q37444094-0B61A204-5E64-4A36-BEDF-0A293897FAD8Q37610100-EA9DCC16-A17B-4304-BA97-8E4C6A6CD1B0Q37679954-FD839A19-304B-42D5-804D-69412005F841Q37775972-0859C369-5F1B-4547-AC9F-80FC955C29F5Q37857064-8C91AB83-1CDB-4C9A-9464-43B79C0B7072Q37993466-E0A96139-A3AD-44D1-9784-F0982E96EDC9Q38007179-F6358994-F820-44EE-B292-61979C5F2BF6Q38042256-1EF35877-E9BB-4946-B70B-6CDECE64E096Q38463092-6F409C7A-57F9-48C9-B388-88516BE13AA5Q38746607-3BE2F24A-8B48-422F-B3C4-CDC91E2D3769Q38768447-1ECA99A9-121C-4ED5-BD56-ABB25AF27641Q38887307-44F66074-C5E0-4F5D-9D2F-6F3F4162E303Q39257035-7CF00351-BCCD-4BF3-8EF0-434B720F1324
P2860
Tumor-specific anti-nucleosome antibody improves therapeutic efficacy of doxorubicin-loaded long-circulating liposomes against primary and metastatic tumor in mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tumor-specific anti-nucleosome ...... and metastatic tumor in mice.
@en
Tumor-specific anti-nucleosome ...... and metastatic tumor in mice.
@nl
type
label
Tumor-specific anti-nucleosome ...... and metastatic tumor in mice.
@en
Tumor-specific anti-nucleosome ...... and metastatic tumor in mice.
@nl
prefLabel
Tumor-specific anti-nucleosome ...... and metastatic tumor in mice.
@en
Tumor-specific anti-nucleosome ...... and metastatic tumor in mice.
@nl
P2860
P356
P1476
Tumor-specific anti-nucleosome ...... and metastatic tumor in mice.
@en
P2093
Tamer A Elbayoumi
Vladimir P Torchilin
P2860
P304
P356
10.1021/MP8001528
P407
P577
2009-01-01T00:00:00Z